Carl Zeiss Meditec Grows Revenue, Earnings in the First Nine Months of 2024-25

Published on August 8, 2025
JENA, Germany—Carl Zeiss Meditec (ISIN: DE0005313704) reported yesterday on the first nine months of fiscal year 2024/25, announcing revenue of €1,600.1 million compared with €1,486.5 million in the prior year, corresponding to growth of 7.6 percent. Adjusted for currency and acquisition effects, revenue growth of 1.1 percent was slightly above the prior year's figure, the company advised. Order intake rose significantly at 23.3 percent, the company said, and earnings before interest, taxes and amortization (EBITA) increased to €175.4 million, compared with the prior-year period at €170.2 million.
Continue reading on website
Other news

Parental lag time is primary reason for delayed diagnosis and treatment of retinoblastoma

August 7, 2025
Ocular salvage and preservation of vision are essentially dependent on early diagnosis, and several studies have been conducted to identify the factors leading to delayed diagnosis at presentation.

The future of optometry: Dr Rachelle Lin taking the low vision world by storm

August 8, 2025
Rachelle Lin, OD, MS, FAAO, has refined her passions for academia, teaching, low vision practice, and advocacy work to build out a well-rounded career.